Amicus Therapeutics
FOLD
FOLD
225 hedge funds and large institutions have $3.3B invested in Amicus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 58 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $3.57B → $3.3B (-$268M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
31% less call options, than puts
Call options by funds: $4.41M | Put options by funds: $6.36M
Holders
225
Holding in Top 10
6
Calls
$4.41M
Puts
$6.36M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$19.2M | |
| 3 | +$17.2M | |
| 4 |
Millennium Management
New York
|
+$16.3M |
| 5 |
O
OrbiMed
New York
|
+$7.26M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$14.8M | |
| 3 | -$10.6M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$7.77M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.57M |